Actively Recruiting

Phase Not Applicable
Age: 18Years - 43Years
FEMALE
NCT02846064

Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function

Led by Centre Hospitalier Universitaire de Besancon · Updated on 2024-07-12

50

Participants Needed

1

Research Sites

587 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire de Besancon

Lead Sponsor

C

CHU de Reims

Collaborating Sponsor

AI-Summary

What this Trial Is About

Ovarian cryopreservation is one of the available option for preserving fertility prior to potentially sterilizing treatments. In the absence of other techniques such as in vitro folliculogenesis or injection of isolated ovarian follicles, this tissue can only be re-used by autograft. In France, the first live birth after orthotopic ovarian transplantation, was obtained by Roux et al. in 2009. This clinical trial aims to collect data on the efficiency of the graft in terms of restoration of ovarian function and live births. It will also allow us to carry out the patient follow-up after ovarian tissue cryopreservation and after autograft when achieved. In cases of neoplastic malignancies, minimal residual disease detection will be performed on ovarian tissue, to avoid any risk of cancer re-seeding.

CONDITIONS

Official Title

Development of Ovarian Tissue Autograft in Order to Restore Ovarian Function

Who Can Participate

Age: 18Years - 43Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who underwent Ovarian tissue cryopreservation
  • Premature ovarian failure
  • Patients cured of their primary disease
  • Women between 18 and 43 years of age
  • Patients who have already benefited from ovarian tissue autograft
Not Eligible

You will not qualify if you...

  • Patients under trusteeship
  • Patients placed in receivers
  • Patients under the protection of a conservator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

CHRU Besancon

Besançon, France, 25030

Actively Recruiting

Loading map...

Research Team

C

Clotilde AMIOT, MD PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here